IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH)

CUSIP: 23254X201

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Class A common stock, $0.001 par value
Shares outstanding
162,474,849
Total 13F shares
71,184
Share change
-522,083
Total reported value
$583,000
Price per share
$8.18
Number of holders
7
Value change
-$3,341,359
Number of buys
5
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 23254X201?
CUSIP 23254X201 identifies CYTH - IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) as of Q1 2021

As of 31 Mar 2021, IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 71,184 shares. The largest 7 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, AIGH Capital Management LLC, ROYAL BANK OF CANADA, UBS Group AG, MORGAN STANLEY, and CAPTRUST FINANCIAL ADVISORS. This page lists 7 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.